OR WAIT null SECS
March 01, 2002
When FDA reviewed PDA's Technical Report No. 34 about isolator systems, significant differences of opinion between the organizations came to light.
The development of a successful powder for injection formulation requires careful study of preformulation parameters, packaging and process parameters, and the elimination of particulate matter.
October 02, 2001
Two types of hydrogels used in parenteral protein-delivery systems offer opportunities for achieving a variety of prolonged- and delayed-release patterns.
July 01, 2001
Significant advances have shaped the past 25 years in the pharmaceutical industry, and the next 25 years will be no exception.